临床外科杂志 ›› 2022, Vol. 30 ›› Issue (3): 280-283.doi: 10.3969/j.issn.1005-6483.2022.03.022

• 论著 • 上一篇    下一篇

膀胱癌病人癌组织中Dickkopf相关蛋白2的表达及与预后的相关性

  

  1. 作者单位:100039 北京,中国人民解放军总医院第三医学中心泌尿外科(李玉柱);河北省唐山中心医院泌尿外科(夏连杰)
  • 收稿日期:2021-09-28 接受日期:2021-09-28 出版日期:2022-03-20 发布日期:2022-03-20

Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis

  • Received:2021-09-28 Accepted:2021-09-28 Online:2022-03-20 Published:2022-03-20

摘要: 目的 探讨膀胱癌病人癌组织中Dickkopf相关蛋白2(DKK2)的表达及与预后的关系。 方法 2016年5月~2018年6月我院收治的拟行手术治疗的膀胱癌病人86例,收集病人膀胱癌组织标本和癌旁组织(距癌组织≥5 cm),比较癌组织、癌旁组织中DKK2表达情况。分析癌组织中DKK2表达与临床病理特征的关系。Cox回归分析影响膀胱癌病人预后的因素。分析癌组织中DKK2表达与膀胱癌病人预后的关系。 结果 膀胱癌组织DKK2阴性表达率高于癌旁组织,差异有统计学意义( P <0.05)。不同性别、年龄、体质量指数(body mass index,BMI)、吸烟、饮酒、肿瘤数量膀胱癌病人癌组织中DKK2阴性表达率比较,差异无统计学意义( P >0.05);肿瘤最大径≥3 cm、临床分期Ⅲ~Ⅳ期、有淋巴结转移、低分化、脉管侵犯膀胱癌病人癌组织中DKK2阴性表达率分别高于肿瘤最大径<3 cm、临床分期Ⅰ~Ⅱ期、无淋巴结转移、中/高分化、无脉管侵犯病人,差异有统计学意义( P <0.05)。86例膀胱癌病人术后随访3年,共失访5例,81例病人中19例死亡,病死率为23.46%。Cox回归分析显示,临床分期、淋巴结转移、分化程度、DKK2阴性是影响膀胱癌病人预后的独立影响因素(OR= 3.018 、2.267、3.184、4.645, P <0.05)。截止随访结束,DKK2阳性、DKK2阴性膀胱癌病人存活率分别为94.44%、71.43%。DKK2阳性表达病人与DKK2阴性表达病人生存曲线比较,差异有统计学意义( P <0.05)。 结论 膀胱癌组织中DKK2阴性表达率较高,DKK2表达与膀胱癌病人肿瘤最大径、临床分期、淋巴结转移、分化程度及脉管侵犯及预后均具有一定的相关性,监测其表达情况对膀胱癌病人预后评估具有重要参考价值。

关键词: 膀胱癌, 癌组织, Dickkopf相关蛋白2, 预后

Abstract: Objective To investigate the expression of Dickkopf-related protein 2(DKK2) in cancer tissues of patients with bladder cancer and its relationship with prognosis. Methods Eighty-six patients with bladder cancer who were treated in our hospital from May 2016 to June 2018 were selected for surgical treatment of bladder cancer,and bladder cancer tissue specimens and adjacent tissues(≥5 cm from the cancer tissue) were collected.Compare the expression of DKK2 in cancerous tissues and adjacent tissues.Analyze the relationship between DKK2 expression in cancer tissues and clinicopathological characteristics.Cox regression analysis of multiple factors affecting the prognosis of bladder cancer patients.To analyze the relationship between the expression of DKK2 in cancer tissues and the prognosis of bladder cancer patients. Results The negative expression rate of DKK2 in bladder cancer tissue was higher than that in adjacent tissues( P <0.05).There was no significant difference in the negative expression rate of DKK2 in cancer tissues of bladder cancer patients with different gender,age,BMI,smoking,drinking,and the number of tumors( P >0.05).The maximum diameter of the tumor was ≥3 cm,the clinical stage Ⅲ to Ⅳ,there was The negative expression rate of DKK2 in the cancer tissues of patients with lymph node metastasis,poorly differentiated,and vascular invasion of bladder cancer is higher than that in patients with tumors with a maximum diameter of <3 cm,clinical stages Ⅰ to Ⅱ,no lymph node metastasis,moderate/well differentiated,and no vascular invasion.The difference was statistically significant( P <0.05).86 patients with bladder cancer were followed up for 3 years,and 5 cases were lost to follow-up.Of the remaining 81 patients,19 died,with a mortality rate of 23.46%.Cox regression analysis showed that clinical stage,lymph node metastasis,degree of differentiation,and negative expression rate of DKK2 were independent factors affecting the prognosis of bladder cancer patients(OR=3.018,2.267,3.184,4.645, P <0.05).By the end of the follow-up,the survival rates of patients with DKK2-positive and DKK2-negative bladder cancer were 94.44% and 71.43%,respectively.The survival curve of patients with positive expression of DKK2 and patients with negative expression of DKK2 were compared,and the difference was statistically significant( P <0.05). Conclusion The negative expression rate of DKK2 in cyst carcinoma tissues is relatively high.The expression of DKK2 has a certain correlation with tumor diameter,clinical stage,lymph node metastasis,degree of differentiation,vascular invasion and prognosis in patients with bladder cancer.Monitoring its expression is beneficial to patients with bladder cancer Prognosis evaluation has important reference value.

Key words: bladder cancer, cancer tissue, Dickkopf-related protein 2, prognosis

[1] 卢开进 申江峰 贾卫光. 胸腔镜改良喉返神旁经淋巴结清扫治疗食管癌的疗效及对预后的影响[J]. 临床外科杂志, 2022, 30(3): 257-260.
[2] 沈荐 李敏哲 杜燕夫. 中心型肥胖对腹腔镜远端胃癌D2根治术临床疗效的影响[J]. 临床外科杂志, 2022, 30(3): 261-265.
[3] 张顺 丁秋播 庄君龙. 膀胱癌新辅助免疫治疗引起免疫相关性膀胱炎二例[J]. 临床外科杂志, 2022, 30(3): 276-279.
[4] 季金涛 康波 苏燕胜. 前列腺特异性膜抗原在前列腺癌组织中的表达与临床病理特征的关系及预后价值[J]. 临床外科杂志, 2022, 30(2): 130-133.
[5] 李云龙 杜正华 张慧敏 解凤妮 李纪鹏. 胃肠胰神经内分泌肿瘤临床治疗及预后分析[J]. 临床外科杂志, 2022, 30(2): 166-170.
[6] 张明坤 王哲 杨柳 侯兰 张聚良. 黏液性乳腺癌的预后影响因素分析与预后模型构建[J]. 临床外科杂志, 2022, 30(1): 44-50.
[7] 孙政 阙海峰 楼建 徐宏涛. 营养风险指数在Ⅳ期胃癌预后评价中的意义[J]. 临床外科杂志, 2022, 30(1): 58-61.
[8] 胡欣雨 姚晖 夏冬 Sami UL Haq Niazi. 鸟嘌呤核苷酸交换因子在胃癌组织中的表达及其临床意义[J]. 临床外科杂志, 2021, 29(9): 848-852.
[9] 姜小琴 李惠珍. 经尿道膀胱肿瘤电切术同期经尿道前列腺电切术治疗非浸润性膀胱癌伴良性前列腺增生的安全性及有效性研究[J]. 临床外科杂志, 2021, 29(9): 872-875.
[10] 杨晓光, 苏鹏, 陈海洋. 全腔镜Ivor-Lewis术对食管癌根治术病人应激反应及胃肠功能的影响[J]. 临床外科杂志, 2021, 29(8): 726-729.
[11] 谢元润 马迎辉 叶继业 陈超 何畅. 轻型颅脑损伤病人血清高迁移率族蛋白B1、泛素C末端水解酶L1和神经元特异性烯醇化酶水平变化及与预后的相关性分析[J]. 临床外科杂志, 2021, 29(7): 635-638.
[12] 王瀚 丛文铭 郑建明 白辰光 . 结肠肉瘤样癌三例临床病理分析[J]. 临床外科杂志, 2021, 29(7): 656-658.
[13] 侯松林, 谢兴江, 彭强等. 结直肠癌肝转移病人原发灶切除的临床意义及其预后影响因素分析——基于SEER数据库的倾向得分匹配分析[J]. 临床外科杂志, 2021, 29(6): 543-548.
[14] 刘湘萍, 刘承力, 解杰等. 富血小板纤维蛋白在慢性难愈性创面中的临床应用[J]. 临床外科杂志, 2021, 29(6): 580-582.
[15] 李干斌 韩加刚 王振军 魏广辉 渠浩 翟志伟 易秉强 马华崇 杨勇王建良 李竹林. 新辅助放化疗治疗局部进展期直肠癌的远期疗效及预后因素分析[J]. 临床外科杂志, 2021, 29(5): 422-427.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!